Can ligation of the intersphincteric fistula tract (LIFT) fail and convert a low trans‑sphincteric anal fistula (≤30 % external sphincter involvement, no Crohn’s disease, normal continence, tract epithelialised ≥12 months) into a more complex fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can LIFT Surgery Fail Into a More Complex Fistula?

No, LIFT (ligation of the intersphincteric fistula tract) does not convert a low transsphincteric fistula into a more complex fistula when it fails. When LIFT fails, the fistula either persists in its original configuration or, in some cases, converts to a simpler intersphincteric fistula that is actually easier to treat.

What Actually Happens When LIFT Fails

The Failure Pattern

  • LIFT failure results in persistence of the original fistula tract, not progression to more complex disease 1
  • In the specific scenario described (low transsphincteric fistula with ≤30% external sphincter involvement), failed LIFT can actually convert the transsphincteric fistula into an intersphincteric fistula, which is a simpler configuration 1
  • This conversion allows subsequent fistulotomy with complete preservation of the external anal sphincter, making the second procedure safer than the original fistula would have required 1

Timing and Recognition of Failure

  • All LIFT recurrences occur within 2 months after surgery, with median time to failure at approximately 4 months when it does occur 2, 3
  • The recurrence rate ranges from 21-27% in adequately followed cohorts, with most failures presenting between 4-8 weeks postoperatively 4, 3
  • Primary healing rates are 53-82% depending on patient selection, with simple transsphincteric fistulas achieving 80% success versus only 33% for recurrent fistulas 5, 4

Why LIFT Doesn't Create Complexity

The Surgical Mechanism

  • LIFT works by ligating the fistula tract at the intersphincteric level, interrupting the connection between internal and external openings 3
  • The procedure removes infected tissue via an intersphincteric approach while leaving the sphincter complex completely untouched 2, 6
  • When LIFT fails, it simply means the ligation did not hold—the anatomical relationships remain unchanged or simplified 1

Evidence From Clinical Series

  • In a prospective study of 22 patients with low transsphincteric fistulas, the 4 patients (18%) who failed LIFT had their transsphincteric fistulas converted to intersphincteric fistulas, allowing subsequent sphincter-preserving fistulotomy 1
  • Overall healing rate was 100% after accounting for the salvage procedures, with no worsening of continence 1
  • No surgical complications were reported in multiple series, with postoperative complications limited to minor wound issues in up to 14% of cases 4, 7, 3

Clinical Implications for Your Patient

For a Low Transsphincteric Fistula (≤30% External Sphincter)

  • LIFT is a safe first-line option because failure does not burn bridges for future treatment 1, 3
  • The 1.6% incontinence rate with LIFT is dramatically lower than the 7.8% rate with advancement flaps or 57% rate with cutting setons 3
  • Even if LIFT fails, the patient can undergo fistulotomy with the external sphincter preserved, which would not have been possible without attempting LIFT first 1

Critical Success Factors to Optimize

  • Smoking increases failure risk 3.2-fold—counsel patients to quit before surgery 3, 8
  • Active proctitis doubles failure risk—verify absence via examination under anesthesia before attempting LIFT 3
  • Ensure the tract has matured into a fibrotic tube with granulation tissue, ideally epithelialized for ≥12 months 2
  • Single, non-branching fistulas with well-defined anatomy are ideal candidates 3, 8

Common Pitfalls to Avoid

  • Do not attempt LIFT in the presence of active proctitis—this is a critical contraindication that must be ruled out via proctosigmoidoscopy 3
  • Do not proceed with branching or poorly epithelialized tracts—these predict failure and should be managed with alternative approaches 3, 8
  • Do not declare success based on clinical healing alone—MRI confirmation of tract obliteration predicts no reinterventions during long-term follow-up 3
  • Avoid underestimating the impact of smoking—this modifiable risk factor significantly affects outcomes and requires preoperative counseling 3, 8

References

Related Questions

What are the cons of LIFT (Ligation of Intersphincteric Fistula Tract) surgery for a patient with a low transsphincteric fistula and a history of receptive anal sex?
What is the optimal treatment plan for a middle-aged patient with internal soiling, a normal sigmoidoscopy, a mucosal bulge on the left side and indentation in the midline posterior on per rectal (PR) examination, and a pelvic MRI showing a mass on the left side at the levator ani with no external opening?
Is a lift procedure for fistula, such as ligation of the intersphincteric fistula tract (LIFT), fragile indefinitely in patients with underlying conditions like diabetes?
How complex and risky to the pudendal nerves is a LIFT (ligation of intersphincteric fistula tract) compared with a fistulotomy for a low trans‑sphincteric fistula involving 30 % of the external anal sphincter?
Can LIFT (Ligation of Intersphincteric Fistula Tract) procedures fail years later in older adult patients with low transphincteric fistulas?
What is the appropriate atorvastatin dosing regimen for adult patients in primary and secondary cardiovascular prevention, including age‑specific doses, risk‑based intensity, monitoring, contraindications, and escalation steps if LDL‑C targets are not achieved?
What are the current hyperuricemia guidelines for managing gout and related conditions, including treat‑to‑target serum urate levels, first‑line medications, renal dosing adjustments, monitoring, and criteria for discontinuation?
Should atorvastatin be taken with meals or on an empty stomach, and what dietary considerations are required?
What is the recommended initial dose and titration schedule of losartan for an adult with hypertension, including adjustments for elderly or frail patients, moderate (creatinine clearance 30–60 mL/min) or severe renal impairment, heart failure, and diabetic kidney disease?
What are the recommended doses of Budecort (beclomethasone dipropionate) inhaler and Duolin (ipratropium bromide + albuterol) inhaler for a 5‑year‑old child with mild‑to‑moderate asthma?
Why is dapagliflozin not recommended for a patient with autosomal dominant polycystic kidney disease (ADPKD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.